While various community transmission mitigation tactics are being employed in regions across Canada, including stay home mandates, bans on public congregations, and provincial lockdown, public health experts and scientists agree that widespread availability of testing for COVID-19 would aid efforts in more accurately tracking the virus’ spread. This project aims to develop a more sensitive […]

COVID-19 is a highly infectious respiratory disease that is caused by the SARS-CoV-2 virus. RT-qPCR is a nucleic acid testing that is widely adapted to confirm the infection. Point-of-care IgM/IgG testing strips have been adopted in some countries for screening and surveillance. However, these antibody testing strips are restricted to a positive/negative testing result. Because […]

The local and global prevalence of infectious diseases require plenty of healthcare resources. Accurate and on-time diagnostic information is of critical value for appropriate patient treatment and healthcare resource management. Typically, single biomarker testing results are not sufficiently sensitive and specific to achieve the high accuracy of diagnosis and stratification. Testing multiple biomarkers (e.g. inflammatory […]

Infectious diseases from a variety of pathogens can lead to serious health conditions such as sepsis. To improve the prognosis and decrease the mortality rate of infectious diseases, point-of-care testing (POCT) of blood biomarkers is a critical approach. Testing of biomarkers such as C-reactive protein, IL-6 and procalcitonin could help identify the type of pathogen […]